Ellipsis Health applies artificial intelligence to the field of mental healthcare, developing tools that analyze vocal biomarkers and speech patterns. The company's work sits at the intersection of conversational AI, speech analysis, and clinical research, with the stated goal of improving patient outcomes while reducing administrative tasks for healthcare providers.
The company's primary product is Sage, described as an AI Care Manager designed for healthcare management across the patient journey. The system is HIPAA-compliant and intended to be emotionally intelligent, purpose-built for the operational demands of healthcare settings. Ellipsis Health's approach is grounded in clinical research and real-world validation.
Ellipsis Health serves health plans, health systems, and specialty care organizations across the United States. The company has a stated focus on improving access to care for underserved populations. Its technical work spans AI development, vocal biomarker technology, and the application of speech analysis to mental health contexts.
